Physician profile
Susan Jaros
NPI 1982045688
$5,882.44
in general payments reported to CMS, 2019-2025
36 companies · $1,245 in 2025
The $1,245 reported for 2025 was more than what 93% of Occupational Health (Nurse Practitioner) providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,047 · 2022: $1,198 · 2023: $996 · 2024: $1,397 · 2025: $1,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,637.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $662.02 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $477.57 | 2021-2025 | Austedo Xr, Austedo |
| Janssen Pharmaceuticals, INC | $358.68 | 2021-2024 | Xarelto |
| Inspire Medical Systems, INC. | $286.28 | 2023-2024 | Inspire |
| Neurocrine Biosciences, INC. | $277.30 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $249.92 | 2024 | Ultomiris |
| Otsuka America Pharmaceutical, INC. | $210.68 | 2023-2025 | Rexulti |
| Amgen INC. | $203.15 | 2022-2025 | Evenity |
| Acadia Pharmaceuticals INC | $188.22 | 2022 | |
| Lilly USA, LLC | $183.71 | 2021-2025 | Mounjaro, Kisunla |
| Jazz Pharmaceuticals INC. | $183.33 | 2023 | |
| Inari Medical, INC. | $151.34 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $143.00 | 2022-2023 | Wegovy |
| Biohaven Pharmaceuticals, INC. | $141.03 | 2021 | |
| Biogen, INC. | $136.79 | 2022-2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $134.58 | 2022-2024 | |
| Lundbeck LLC | $125.00 | 2022 | |
| Idorsia Pharmaceuticals US INC | $124.99 | 2023 | Quviviq |
| Madrigal Pharmaceuticals | $124.04 | 2025 | Rezdiffra |
| Avanir Pharmaceuticals, INC. | $122.84 | 2021 | |
| Vanda Pharmaceuticals INC. | $122.42 | 2025 | Ponvory |
| Avadel Cns Pharmaceuticals, LLC | $119.70 | 2025 | Lumryz |
| Alkermes, INC. | $119.39 | 2024 | Vivitrol |
| Mdd US Operations, LLC | $117.34 | 2025 | |
| Stryker Corporation | $116.12 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sage Therapeutics, LLC | $111.91 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.00 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $86.37 | 2025 | Cobenfy |
| Sk Life Science, INC. | $86.06 | 2022 | |
| Neurelis, INC. | $77.75 | 2024 | Valtoco |
| Phathom Pharmaceuticals, INC. | $71.53 | 2025 | Voquezna |
| Lexicon Pharmaceuticals, INC. | $66.08 | 2024 | Inpefa |
| Harmony Biosciences LLC | $63.54 | 2022 | |
| Amneal Pharmaceuticals LLC | $51.86 | 2022 | |
| Nevro Corp. | $49.91 | 2021 | |
| Silk Road Medical, INC. | $37.99 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Jaros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.